Technical Analysis for NOVN - Novan, Inc.

Grade Last Price % Change Price Change
grade B 2.76 -1.08% -0.03
NOVN closed down 1.08 percent on Thursday, September 19, 2019, on 87 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Up Up Up
See historical NOVN trend table...

Date Alert Name Type % Chg
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.00%
NR7 Range Contraction 0.00%
Inside Day Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup -1.08%
Outside Day Range Expansion -1.08%
Wide Bands Range Expansion -1.08%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 2.99%
Upper Bollinger Band Walk Strength 2.99%
Wide Bands Range Expansion 2.99%

Older signals for NOVN ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Novan, Inc. is a late-stage pharmaceutical company. The Company is engaged in the development and commercialization of therapies using its nitric oxide platform. The Company develops product candidates using its Nitricil technology, which enables the Company to engineer tunable new chemical entities (NCEs). The Company's formulation science enables it to further tune the release of nitric oxide when applied to the skin by using the combinations of inactive ingredients. It is developing SB204 for the treatment of acne vulgaris in Phase III. The Company is developing its product candidate, SB206, for the treatment of external genital and perianal warts in Phase II. It is developing SB208, an investigational topical anti-fungal for the treatment of fungal infections of the skin and nails. It is developing SB204 for the treatment of inflammatory skin diseases. Its pipeline also includes SB414, a topical cream product candidate.
Medical Specialties Organ Systems Infectious Diseases Acne Product Candidates Acne Vulgaris Cutaneous Conditions Fungal Infections Inflammatory Skin Diseases Treatment Of Inflammatory Skin Diseases Wart
Is NOVN a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 4 bullish, 0 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicator Value
52 Week High 3.24
52 Week Low 0.65
Average Volume 64,252
200-Day Moving Average 1.7761
50-Day Moving Average 2.5644
20-Day Moving Average 2.516
10-Day Moving Average 2.742
Average True Range 0.2289
ADX 27.38
+DI 18.7455
-DI 13.1659
Chandelier Exit (Long, 3 ATRs ) 2.3233
Chandelier Exit (Short, 3 ATRs ) 2.6867
Upper Bollinger Band 3.0232
Lower Bollinger Band 2.0088
Percent B (%b) 0.74
BandWidth 40.317965
MACD Line 0.084
MACD Signal Line 0.045
MACD Histogram 0.039
Fundamentals Value
Market Cap 44.11 Million
Num Shares 16 Million
EPS -4.08
Price-to-Earnings (P/E) Ratio -0.68
Price-to-Sales 129.29
Price-to-Book 8.46
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 2.97
Resistance 3 (R3) 2.98 2.91 2.94
Resistance 2 (R2) 2.91 2.86 2.91 2.92
Resistance 1 (R1) 2.84 2.83 2.81 2.83 2.91
Pivot Point 2.77 2.77 2.76 2.77 2.77
Support 1 (S1) 2.70 2.72 2.67 2.69 2.61
Support 2 (S2) 2.63 2.69 2.63 2.60
Support 3 (S3) 2.56 2.63 2.59
Support 4 (S4) 2.55